4//SEC Filing
Wang Xiaolin 4
Accession 0001567619-21-005846
CIK 0001628171other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:41 PM ET
Size
7.2 KB
Accession
0001567619-21-005846
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Award
Common Stock
2021-03-04+11,200→ 11,944 total - Award
Stock Option (Right to Buy)
2021-03-04+39,200→ 39,200 totalExercise: $42.45Exp: 2031-03-03→ Common Stock (39,200 underlying)
Footnotes (2)
- [F1]Includes 11,200 Restricted Stock Units.
- [F2]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 4, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001849181
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 7:41 PM ET
- Size
- 7.2 KB